Clinical Trial Update: ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

View source ↗

Summary

This update reports that the ItaliaN observational study of patients with Acute Lymphoblastic Leukemia treated with an anti-CD22 immunoconjugate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Anti-CD22 immunoconjugate

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Acute Lymphoblastic Leukemia | Status: COMPLETED